Company: TVRD
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001104659-25-097519
Chunk: 374

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-07
Form: S-1/A
Chunk 374
---
 reference from Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No. 001-36279), filed with the SEC on November 20, 2019). |
| ​      | ​ | ​                                                                                                                                                                                                                                |
| 10.27  | ​ | Form of Lock-Up Agreement, dated December 17, 2024 (incorporated by reference from Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No. 001-36279), filed with the SEC on December 18, 2024).                   |
| ​      | ​ | ​                                                                                                                                                                                                                                |

| 21.1** | ​ | List of Subsidiaries |

| ​     | ​ | ​                                                                                |
| ​     | ​ | ​                                                                                |
| 23.1* | ​ | Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm. |
| ​     | ​ | ​                                                                                |

| 23.2** | ​ | Consent of Cooley LLP (included in Exhibit 5.1). |
| ​      | ​ | ​                                                |
| 24.1** | ​ | Power of Attorney.                               |
| ​      | ​ | ​                                                |
| 107**  | ​ | Filing Fee Table                                 |

| * | Filed herewith |

| ** | Previously filed |

| 

# | Indicates a management contract or any compensatory plan, contract or arrangement. |
| † | Certain portions of this exhibit (indicated by asterisks) have been omitted because they are not material and are the type of information that the Company treats as private or confidential. |

| ‡ | Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant undertakes to furnish supplemental copies of any of the omitted schedules upon request by the SEC. |

| (b) | Financial Statement Schedules. All financial statement schedules are omitted because the information called for is not required or is shown either in the consolidated financial statements or in the notes thereto. |

II-5

ITEM 17. UNDERTAKINGS. (a) The undersigned Registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i) To include any prospectus required by section 10(a)(3) of the Securities Act; (ii